IH
Ihuman Inc
NYSE: IH · CONSUMER DEFENSIVE · EDUCATION & TRAINING SERVICES
$1.65
-8.99% today
Updated 2026-06-03
Market cap
$79.74M
P/E ratio
5.78
P/S ratio
0.10x
EPS (TTM)
$0.27
Dividend yield
4.31%
52W range
$1 – $3
Volume
0.0M
WallStSmart proprietary scores
39
out of 100
Grade: D
Sell
Investment rating
2.0
Growth
F9.0
Quality
A+5.0
Profitability
C+8.3
Valuation
A4/9
Piotroski F-Score
Moderate
3.2
Altman Z-Score
Safe zone
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$3.86
+133.94%
12-Month target
$1.59
-3.64%
Intrinsic (DCF)
$11.02
Margin of safety
+81.34%
Price chart
Stock snapshot
Strengths
+ Altman Z 3.22 — safe zone
+ 81.34% below intrinsic value
+ Debt/equity 0.01x — low leverage
Risks
- Revenue declining -18.10% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $985.52M | $1.02B | $922.20M | $807.02M | $807.02M |
| Net income | $109.82M | $180.91M | $98.59M | $95.40M | $15.20M |
| EPS | — | — | — | — | $0.27 |
| Free cash flow | $1.25B | $165.61M | $51.10M | $45.15M | — |
| Profit margin | 11.14% | 17.77% | 10.69% | 11.82% | 11.80% |
Peer comparison
Smart narrative
Ihuman Inc trades at $1.65. representing a P/E of 5.78x trailing earnings. Our Smart Value Score of 39/100 indicates the stock is weak. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of 3.22, it sits in the safe zone. TTM revenue stands at $807.02M. with profit margins at 11.80%. Our DCF model estimates intrinsic value at $11.02.
Frequently asked questions
What is Ihuman Inc's stock price?
Ihuman Inc (IH) trades at $1.65, on a P/E of 5.8x and a P/S of 0.1x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is Ihuman Inc overvalued?
Ihuman Inc carries a Smart Value Score of 39/100 (Grade D), which we rate Sell. That score blends growth, quality, and valuation into one read. Our DCF puts intrinsic value at $11.02 versus the $1.65 price, a 81.3% margin of safety on a cash flow basis.
What is the price target of Ihuman Inc (IH)?
The 12-month analyst consensus target is $3.86, about 133.9% above the current $1.65. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is the intrinsic value of Ihuman Inc (IH)?
Our DCF model estimates intrinsic value at $11.02, a +81.3% margin of safety versus today's $1.65. Intrinsic value is what the projected cash flows are worth today. A positive reading means the price sits below that estimate, leaving a cushion if growth holds.
What is Ihuman Inc's revenue?
Ihuman Inc's trailing twelve-month revenue is $807.02M. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
Ihuman Inc's Altman Z-Score is 3.22, which places it in the safe zone. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorCONSUMER DEFENSIVE
IndustryEDUCATION & TRAINING SERVICES
CountryChina
ExchangeNYSE
CurrencyUSD
Quick metrics
P/S ratio0.10x
ROE8.44%
Beta0.09
50D MA$1.69
200D MA$2.22
Shares out0.02B
Float0.07B
Short ratio—
Avg volume0.0M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—